Amicus Therapeutics
Michel Boggio is an experienced professional in the pharmaceutical and healthcare sectors, currently serving as the Regional Key Account Manager at Amicus Therapeutics since November 2016, where responsibilities include identifying key stakeholders in the context of Fabry disease and launching personalized therapeutic options. Prior roles include Medical Science Liaison at TEVA Santé, focusing on neurology and establishing partnerships with top KOLs, as well as District Sales Manager, where leadership and innovative training initiatives contributed to significant sales of Copaxone® and Azilect®. Michel has held various positions in marketing and sales, including Key Account Manager at Merck Serono France and product management roles at Serono France and Liphaderm, showcasing a strong background in neurology and dermatology markets. Educational credentials include attendance at the Paris School of Business from 2012 to 2017.
This person is not in any teams
This person is not in any offices
Amicus Therapeutics
4 followers
Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.